Statistical Methods for Cancer Clinical Trials
癌症临床试验的统计方法
基本信息
- 批准号:8462924
- 负责人:
- 金额:$ 202.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-01 至 2015-03-31
- 项目状态:已结题
- 来源:
- 关键词:Cancer PatientClinical TrialsClinical Trials DesignCommunicationComputational ScienceComputer softwareDataData AnalysesGoalsHealthLeadLongevityMalignant NeoplasmsMethodologyMethodsPharmacogeneticsPhaseProcessPublic HealthStatistical MethodsTranslationsTreatment Protocolscancer therapyclinical practicecomparative effectivenessdesigneffectiveness researchimprovedinnovationnovel strategiesprognosticprogramstool
项目摘要
DESCRIPTION (provided by applicant): The overall scientific goal of this ambitious program project is to develop highly innovative methods for cancer clinical trials that can hasten successful introduction of effective new therapies into practice. The method of approach is to leverage recent advances in statistical and computational science to create new clinical trial designs and data analysis tools that resolve many of the key scientific limitations of current clinical trial methodology. The projects focus on practical design and analysis problems in Phase II and Phase 111 clinical trials, the problem of missing data and efficient use of prognostic information, postmarketing surveillance and comparative effectiveness research using clinical trial data, pharmacogenetics and individualized therapies, and the potential of dynamic treatment regimens to improve cancer treatment. The proposed clinical trial design and analysis innovations have the potential to change the prevailing clinical trial paradigm and greatly increase the rate of discovery and translation of new treatments into clinical practice. Our multi-institutional approach includes an effective and energetic process for intense, coordinated implementation, communication and dissemination of results, including developing new software for practical implementation of the newly developed methods. Our comprehensive and novel approach will lead to significant improvements in cancer clinical trial practice that will result in improved health of cancer patients.
描述(由申请人提供):这个雄心勃勃的项目的总体科学目标是为癌症临床试验开发高度创新的方法,从而加速将有效的新疗法成功引入实践。方法是利用统计和计算科学的最新进展来创建新的临床试验设计和数据分析工具,解决当前临床试验方法的许多关键科学限制。这些项目侧重于II期和111期临床试验的实际设计和分析问题、数据缺失和预后信息的有效利用问题、上市后监测和使用临床试验数据的比较有效性研究、药物遗传学和个体化治疗,以及动态治疗方案改善癌症治疗的潜力。提出的临床试验设计和分析创新有可能改变现行的临床试验范式,并大大提高新疗法的发现和转化为临床实践的速度。我们的多机构方法包括一个有效和积极的过程,以加强、协调的实施、沟通和传播结果,包括为实际实施新开发的方法开发新的软件。我们全面而新颖的方法将导致癌症临床试验实践的重大改进,从而改善癌症患者的健康状况。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARIE DAVIDIAN其他文献
MARIE DAVIDIAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARIE DAVIDIAN', 18)}}的其他基金
Engaging, Inspiring, and Preparing the Next Generation of Biostatisticians
吸引、激励和培养下一代生物统计学家
- 批准号:
9075554 - 财政年份:2016
- 资助金额:
$ 202.99万 - 项目类别:
Mthods For Missing and auxiliary Data in clinical trials
临床试验中缺失数据和辅助数据的处理方法
- 批准号:
7786679 - 财政年份:2010
- 资助金额:
$ 202.99万 - 项目类别:
Engaging, Inspiring, and Preparing the Next Generation of Biostatisticians
吸引、激励和培养下一代生物统计学家
- 批准号:
7754969 - 财政年份:2009
- 资助金额:
$ 202.99万 - 项目类别:
相似海外基金
From lymphatics to evaluating resolution therapeutics in clinical trials
从淋巴管到评估临床试验中的解决疗法
- 批准号:
MR/Y013050/1 - 财政年份:2024
- 资助金额:
$ 202.99万 - 项目类别:
Fellowship
RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network
RareKids-CAN:儿科罕见病临床试验和治疗网络
- 批准号:
495575 - 财政年份:2023
- 资助金额:
$ 202.99万 - 项目类别:
Operating Grants
Unbiased estimation in hierarchical models for Clinical trials
临床试验分层模型中的无偏估计
- 批准号:
2884930 - 财政年份:2023
- 资助金额:
$ 202.99万 - 项目类别:
Studentship
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 202.99万 - 项目类别:
NIDA Clinical Trials Network: New York Node
NIDA 临床试验网络:纽约节点
- 批准号:
10855627 - 财政年份:2023
- 资助金额:
$ 202.99万 - 项目类别:
CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM-NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK-FEMALE SITES-CORE FUNCTION ACTIVITIES
CCTN-避孕发展计划-NICHD避孕临床试验网络-女性站点-核心功能活动
- 批准号:
10895949 - 财政年份:2023
- 资助金额:
$ 202.99万 - 项目类别:
CONTRACEPTIVE CLINICAL TRIALS NETWORK, CCTN - FEMALE SITES 'CORE FUNCTION ACTIVITIES
避孕临床试验网络,CCTN - 女性站点的核心功能活动
- 批准号:
10891325 - 财政年份:2023
- 资助金额:
$ 202.99万 - 项目类别:
ISimcha Technology Platform for Recruiting a Diverse Population of Older Adults into Clinical Trials
ISimcha 技术平台,用于招募不同的老年人群进行临床试验
- 批准号:
10761602 - 财政年份:2023
- 资助金额:
$ 202.99万 - 项目类别:
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)
在津巴布韦实施艾滋病毒/宫颈癌预防 CASCADE 临床试验 (ZIM-CASCADE)
- 批准号:
10758129 - 财政年份:2023
- 资助金额:
$ 202.99万 - 项目类别: